The effect of the glutamate analogue L-a aminoadipate (aAA) on the release of glutamate and ,),-amino butyric acid (GAB A) from rat hippocampal slices was investi gated in vitro. Oxygen/glucose deprivation caused a large re lease of glutamate and GABA. aAA added during energy deprivation reduced the glutamate release in a dose-dependent Brain cells maintain steep gradients of amino acids across the pl£sma membrane by means of specific carrier systems (Nicholls and Attwell, 1990). High affinity up take of glutamate and ,),-aminobutyric acid (GABA) is relatively well characterized, and several of the carrier proteins involved have been cloned (Guastella et aI., 1990; Kanai and Hediger, 1992; Pines et aI., 1992). Low affinity glutamate transport in brain tissue has been shown (Logan and Snyder, 1971), but the function of these carriers of has been less studied (Nicholls and At twell, 1990). The glutamate efflux that occurs during energy depri vation of the brain, has been accounted for by different mechanisms. A calcium-dependent vesicular release may play a role in the early and late stages of cerebral isch emia (Katayama et aI., 1991), but the largest part of glutamate is probably released by calcium-independent, nonvesicular mechanisms (Ikeda et aI., 1989; Hegstad et aI., 1993). The major shift of ions across the plasma membrane that takes place (Hansen and Zeuthen, 1981) may result in the reversal of high-affinity carriers (Ni cholls and Attwell, 1990), or activation of the mecha nisms that operate during osmotic stress (Kimelberg et aI., 1990).
manner (56% reduction at 5 mM), whereas GAB A release was unchanged. We speculate that ischemic glutamate release from the brain is mediated by a low affinity transport mechanism that is blocked by aAA. Key Words: Cerebral ischemia Glutamate-GABA-Amino acid release-Brain slices-L-a aminoadipate.
In this article we show that L-a-aminoadipate, a glu tamate analogue with several different effects, reduces the ischemic release of glutamate from rat brain.
METHODS
Hippocampal slices were prepared as described previously (Langmoen and Andersen, 1981) . In brief, male Wi star rats (100-200 g) were decapitated, the brains were cooled for 2 min in artificial cerebrospinal fluid (ACSF) at 4°C, and the hippo campus was carefully dissected into 0.5 mm thick transverse slices. The slices were then incubated in ACSF saturated by a gas mixture containing 95% O2 and 5% CO2 for a 60-90 min rest period. The ACSF consisted of (in mM) NaCI 123; KCI 3.75; KH2P04 1.25; MgS02 1; CaCl2 2; NaHC0 3 26; glucose (dextro-rotated) 10. The pH was 7.4.
The slices were then placed on transportable grids sub merged in wells containing ACSF (35°C). After 30 min, the grids supporting the slices were transferred to five different test wells containing (1) control conditions: ACSF saturated with 95% O2/5% CO2 (test well A-control); (2) ACSF with 0 mM glucose, and oxygen substituted by 95% N2 (energy depriva tion, [ED])(test well B); (3) ACSF with 0 mM glucose/95% N2, and 0.2 mM L-a-aminoadipate added (ED/aAA 0.2 mM)(test well C); (4) ED/aAA 1 mM (test well D); and (5) ED/aAA 5 mM (test well E). The slices were kept in these test wells for 20 min, then removed for determination protein content. ACSF samples were collected from the wells for amino acid determi nation, cleaned, and deproteinized by ultracentrifugation through a 5 x 10 3 Dalton cut-off filter (Nihon Millipore, Yon ezawa, Japan), and stored at -70°C until analysis.
The content of glutamate and GABA in the ACSF was de termined by high performance liquid chromatography (HPLC, Perkin Elmer, Norwalk, CT, U.S.A) after precolumn derivation with o-phthalaldehyde (Fluka Chemie AG, Buchs, Switzer land)/3-mercapto propionic acid (Sigma, St. Louis, MO, 568 T. S. HAUGSTAD AND 1. A. LANGMOEN U.S.A) at pH 10.5 (Haugstad et aI., 1995) . Fluorescence peaks (Perkin Elmer LC 240, excitation wavelength 340 nm, emission wavelength 460 nm) were integrated by Perkin Elmer 1020X software.
The protein content of the slices was determined according to the method of Lowry (Lowry et aI., 1951) . The results were tested statistically using the Wilcoxon rank sum test and are presented as mean ± standard deviation.
RESULTS
During control conditions (test well A), the slices re leased 920 ± 320 pmol glutamate per mg protein (n = 7). Slices exposed to 20 min of combined oxygen and glu cose deprivation (test well B) released 21,260 ± 6,880 pmol/mg (2,310% of control, p = 0.018). The slices exposed to 0.2 mM aAA during energy deprivation (test well C), released 16,320 ± 4,320 pmol/mg (76% of well B, p = 0.063). Those exposed to 1 mM aAA (well D) released 9,710 ± 1,730 pmol/mg (46% of well B, p = 0.028), and those exposed to 5 mM aAA (well E) re leased 9,350 ± 2,220 pmol/mg (44% of B, p = 0.018).
Thus, aAA significantly reduced the release of glutamate during energy deprivation in a dose-dependent manner (Fig. l) .
The GAB A release during control conditions (A) was 420 ± 330 pmol/mg (n = 7). During energy deprivation (B) it increased to 8,060 ± 2,700 pmol/mg (1,920% of control, p = 0.018). Slices exposed to energy depriva tion with 0.2 mM aAA added (C) released 7,060 ± 1,180 pmol/mg (88% of B), those exposed to ED with I mM aAA added (D) released 8590 ± 1720 pmol/mg (107% of B), and slices exposed to ED with 5 mM aAA present (E), released 8640 ± 3030 pmol/mg (107% of B, see Fig. 2). None of these concentrations of aAA significantly affected the GABA release from the slices exposed to energy deprivation. 
DISCUSSION
Several uptake systems for glutamate and GABA have been described (Christensen, 1984; Danbolt, 1994) , So dium dependent high affinity transport of glutamate and GABA in the brain is well characterized (Guastella et a!., 1990; Nicholls and Attwell, 1990; Kanai and Hediger, 1992; Pines et a!., 1992) . Low affinity carriers of amino acids have been extensively studied in peripheral cells (Christensen, 1984; Bannai, 1986; Miura et aI., 1992) and in synaptosomal vesicles from the brain (Naito and Ueda, 1985; Fykse and Fonnum, 1988; Maycox et aI., 1990) . Low affinity uptake probably also participates in removing peak glutamate concentrations (",1 mM) dur ing synaptic transmission (Waniewski and Martin, 1984; Clements et aI., 1992) aAA has complex effects on brain cells, It inhibits high-affinity glutamate uptake when tested in synapto somes (Robinson et aI., 1991) . Transport studies of the cloned glutamate carriers have shown that aAA inhibits the glial transporter GL T -1 (Pines et aI., 1992) and the neuronal transporter EAAC (ICso = 165 ],LM) (Kanai and Hediger, 1992) , but not the GLAST -I carrier (Klockner et aI., 1994) . In addition, aAA inhibits the glutamate/cystine antiporter (Bannai, 1986; Miura et aI., 1992; Kato et aI., 1993) . Further, it is a selective glio toxin (Olney et aI., 1971; Lund Karlsen, 1978) . Recently, aAA has been shown to inhibit glutamate release from microglia evoked by bacterial toxins (Pi ani and Fontana, 1994) . aAA is a potent inhibitor of low-affinity gluta mate uptake into presynaptic vesicles (Fykse et aI., 1992) . It inhibits the glial enzymes glutamine synthetase and -y-glutamylcysteine synthetase (McBean, 1994) . The D-form is also a potent antagonist at the NMDA receptor (Watkins et aI., 1990; Clements et aI., 1992) .
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The present study shows that aAA efficiently inhibits the release of glutamate evoked by energy deprivation from rat brain in a concentration range from 10-4 to 10-3 M, the same range that inhibits high affinity glutamate uptake in synaptosomes from rat cerebral cortex (Rob inson et aI., 1991) . GABA release was unaffected. The results indicate that the two amino acids at least in part are liberated by separate mechanisms. We have shown earlier that (1) ischemic glutamate release occurs by mechanisms separate from osmotic release (Haugstad et aI., 1995; Haugstad and Langmoen, 1996) ; 2) high affinity uptake inhibitors increase ischemic glutamate ef flux by blocking uptake rather than increasing release (Haugstad, 1996) ; (3) (Kato et aI., 1993; Danbolt, 1994; Hegstad et aI., 1995) , may be involved in the ischemic release of glutamate from brain tissue. The results further point towards the possibility that ischemic release and the release evoked by inflammatory processes may share common mecha nisms (Piani and Fontana, 1994) .
